da Silva Ferreira, Aryostennes Miquéias
Medeiros Silva, César Augusto
Pegado de Abreu Freitas, Rodrigo
de Brito Macedo, Liane
Gabriel de Souza, Clécio
Article History
Received: 10 February 2024
Accepted: 24 December 2025
First Online: 31 March 2026
Declarations
:
: This study describes a single-blind placebo-controlled randomized clinical trial protocol registered in the clinical trials platform and approved by the research ethics committee (protocol number: 3.737.749) of the Faculty of Health Sciences of Trairi—Federal University of Rio Grande do Norte (FACISA/UFRN). After being informed about the aims and procedures of the study, eligible individuals will provide a written informed consent form.
: Informed consent to publish was obtained from the study participants.
: The authors declare that they have no competing interests.